Robert Capps
Rheumatology · Knoxville, TNNPI 1336234376
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.1% of the total across 547 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 29 manufacturers, the largest accounting for just 19.6% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $2,196 and has fallen 94.8% since, to $115 in 2025.
Across 547 payments — averaging $15.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$2K
- AbbVie$1K
- Novartis$951
- Johnson & Johnson$757
- Pfizer$683
- UCB, Inc.$497
- plus $3K from 23 others
Across 32 payments — averaging $2472.73 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Pfizer$75K
- Sanofi US Services Inc.$4K
What the payments were for
- Food & beverage$8,50398%
- Education$1442%
- Gifts$180%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen(2 entities) | 101 | $1,700 |
| AbbVie(2 entities) | 108 | $1,498 |
| Novartis | 74 | $951 |
| Johnson & Johnson | 38 | $757 |
| Pfizer | 50 | $683 |
| UCB, Inc. | 27 | $497 |
| GSK | 25 | $472 |
| E.r. Squibb & Sons, L.L.C. | 29 | $387 |
| Lilly USA, LLC | 15 | $270 |
| AstraZeneca | 13 | $205 |
| Radius Health, Inc. | 9 | $177 |
| Regeneron Healthcare Solutions, Inc. | 8 | $172 |
| Sanofi | 7 | $142 |
| Aurinia Pharma U.S., Inc. | 9 | $137 |
| Sobi, Inc | 4 | $108 |
| Genentech USA, Inc. | 6 | $86 |
| Boehringer Ingelheim | 3 | $74 |
| Lundbeck LLC | 4 | $69 |
| Amneal Pharmaceuticals LLC | 3 | $43 |
| Hikma Pharmaceuticals USA | 2 | $35 |
| Mallinckrodt Hospital Products Inc. | 2 | $34 |
| Pacira Therapeutics, Inc. | 2 | $32 |
| Teva Pharmaceuticals USA, Inc. | 2 | $32 |
| Bristol Myers Squibb | 1 | $21 |
| Hospira, Inc. | 1 | $20 |
| Gilead | 1 | $19 |
| Ascend Therapeutics US, LLC | 1 | $18 |
| Biogen | 1 | $15 |
| Merck | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- UBRELVY$102
How this compares
$8,665 in reported general payments places this provider in the 60th percentile of 127 rheumatology providers in Tennessee.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydroxychloroquine Sulfate | 15 | $585 |
Paid to pharmacies, not to this prescriber.
Other rheumatology in Knoxville
- Brett SmithKnoxville$587K
- Kenny SizemoreKnoxville$27K
- Kenneth JohnsenKnoxville$17K
- Christy ParkKnoxville$16K
- Jay WarrrickKnoxville$14K
- William BushKnoxville$12K
- Marcum CollinsKnoxville$12K
- Tonya BakerKnoxville$10K
- James BurnsKnoxville$9K
- Patrick MastinKnoxville$8K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.